Together Trial removes sublingual administration mid-trial

Together Trial, Changes, NCT04727424, Jul 2021

Ivermectin for COVID-19

4th treatment shown to reduce risk in August 2020, now with p < 0.0000000001 from 106 studies, recognized in 24 countries.

No treatment is 100% effective.
Protocols combine treatments.

Together Trial removes sublingual administration mid-trial.
Together Trial et al., 8 Jul 2021, preprint, 1 author.